0
Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial. (linkinghub.elsevier.com)
Authors:
Tchou JC
… Rech AJ
Journal:
EBioMedicine
Published:
2026-11-16
DOI:
https://doi.org/10.1016/j.ebiom.2026.106547
Comments
Login to comment.
No comments yet. Be the first!